Ignite Creation Date:
2024-05-06 @ 7:52 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06162702
Status:
COMPLETED
Last Update Posted:
2023-12-08
First Post:
2023-11-22
Brief Title:
Clinical Study of Fecal Microbiota Transplantation in the Treatment of Small Intestinal Bacterial Overgrowth SIBO
Sponsor:
Shanghai 10th Peoples Hospital
Organization:
Shanghai 10th Peoples Hospital
Study Overview
Official Title:
To Investigate the Efficacy and Safety of Fecal Microbiota Transplantation FMT in the Treatment of Small Intestinal Bacterial Overgrowth SIBO
Status:
COMPLETED
Status Verified Date:
2023-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Small intestinal bacterial overgrowth SIBO is defined as the presence of excessive numbers of bacteria in the small bowel causing gastrointestinal GI symptoms These bacteria are usually coliforms which are typically found in the colon and include predominantly Gram-negative aerobic and anaerobic species that ferment carbohydrates producing gas Fecal Microbiota Transplantation FMT is a therapeutic method to transplant the microbiota from the feces of healthy people into the intestinal tract of patients To explore the overall efficacy and safety of FMT in the treatment of SIBO
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None